{"id":59183,"date":"2024-04-09T22:03:53","date_gmt":"2024-04-09T20:03:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/"},"modified":"2024-04-09T22:03:53","modified_gmt":"2024-04-09T20:03:53","slug":"ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/","title":{"rendered":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b>Earlier the company was awarded the Late Age-related Macular Degeneration Screening and Prediction Model. iHealthScreen is the first company that was awarded two US patents by the USPTO on AMD and Glaucoma screening\/prediction and can be used in primary care (PCP) settings<\/b><\/p>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AI?src=hash\" target=\"_blank\" rel=\"noopener\">#AI<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fihealthscreen.org%2Fscreening%2F&amp;esheet=53924196&amp;newsitemid=20240408316332&amp;lan=en-US&amp;anchor=iPredictTM&amp;index=1&amp;md5=6b3042fc3a6130fe9f087ee1a43c775f\" rel=\"nofollow noopener\" shape=\"rect\">iPredict<sup>TM<\/sup><\/a> glaucoma detection model provides a fully automated detection report for <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fihealthscreen.org%2Fglucoma&amp;esheet=53924196&amp;newsitemid=20240408316332&amp;lan=en-US&amp;anchor=glaucoma&amp;index=2&amp;md5=aacbd5eae1d0184388a5501130d82cc1\" rel=\"nofollow noopener\" shape=\"rect\">glaucoma<\/a> which can be implemented in the primary care settings for screening and detection of early-stage glaucoma. The full US patent was awarded by USPTO on March 26, 2024. Earlier the results were published in a scientific journal and the results will be presented at the Association for Research in Vision and Ophthalmology (ARVO) 2024. The early screening and detection of glaucoma can potentially help prevent the progression to severe glaucoma and save millions of people from blindness.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/5\/ihs_logo_with_white_bg-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/5\/ihs_logo_with_white_bg-01.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/21\/ihs_logo_with_white_bg-01.jpg\"><\/a><\/p>\n<p>\nOnce high-resolution images of the patient\u2019s eyes\/retina have been captured using a color fundus camera and submitted to the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fihealthscreen.org%2Fscreening%2F&amp;esheet=53924196&amp;newsitemid=20240408316332&amp;lan=en-US&amp;anchor=iPredictTM&amp;index=3&amp;md5=039af8dbfb60c321473f79758074827a\" rel=\"nofollow noopener\" shape=\"rect\">iPredict<sup>TM<\/sup><\/a> AI System, the glaucoma detection results are available in a fully automated report in less than 60 seconds. The entire test which includes color retinal imaging and the automated AI-based glaucoma report generation can easily and reliably be completed within 5 minutes.<\/p>\n<p>\nGlaucoma detection offers an overall accuracy of 94.3% for identifying an individual with glaucoma.<\/p>\n<p>\niPredict\u2019s glaucoma detection model can be used as follows:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\niPredict-glaucoma report will produce which will indicate referable (i.e., early to severe glaucoma) or non-referable glaucoma (not glaucoma). For referable glaucoma subjects, patients will be referred to the glaucoma specialists.<\/li>\n<\/ul>\n<p>\nThe company also has AI-based screening tools for early diagnosis of diabetic retinopathy, AMD and glaucoma which are CE certified, MHRA\/UK and TGA\/Australian health approved.<\/p>\n<p>\nIf referable stage disease is detected for any of these conditions, the iPredict automated report recommends a visit to an Ophthalmologist for appropriate treatment. Otherwise, in accordance with standards of care, a follow-up visit is suggested (example, screening again in one year).<\/p>\n<p>\niPredict is indicated for use by healthcare providers in clinics, hospitals, or other healthcare facilities to automatically detect DR, AMD, and glaucoma suspects.<\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ihealthscreen.org&amp;esheet=53924196&amp;newsitemid=20240408316332&amp;lan=en-US&amp;anchor=iHealthScreen&amp;index=4&amp;md5=76f95a9c6e99b0ad0ed7aa770423b8ed\" rel=\"nofollow noopener\" shape=\"rect\">iHealthScreen<\/a> company is open to partnerships within its products. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.iHealthScreen.org&amp;esheet=53924196&amp;newsitemid=20240408316332&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.iHealthScreen.org&amp;index=5&amp;md5=b1149873325e134840a24842b01fe189\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.iHealthScreen.org<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlauddin Bhuiyan, Ph.D.<br \/>\n<br \/>CEO, iHealthScreen Inc.<br \/>\n<br \/>E: <a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#x3a;&#x62;&#x68;&#x75;&#x69;&#x79;an&#64;&#105;&#104;&#101;&#97;&#x6c;&#x74;&#x68;&#x73;&#x63;&#x72;een&#46;&#111;&#114;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x62;&#x68;&#117;&#105;ya&#x6e;&#x40;&#x69;&#104;ea&#x6c;&#x74;&#x68;&#115;&#99;r&#x65;&#x65;&#x6e;&#46;&#111;r&#x67;<\/a><br \/>T: +1 718 926 9000<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Earlier the company was awarded the Late Age-related Macular Degeneration Screening and Prediction Model. iHealthScreen is the first company that was awarded two US patents by the USPTO on AMD and Glaucoma screening\/prediction and can be used in primary care (PCP) settings NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM glaucoma detection model provides a fully automated detection report for &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59183","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Earlier the company was awarded the Late Age-related Macular Degeneration Screening and Prediction Model. iHealthScreen is the first company that was awarded two US patents by the USPTO on AMD and Glaucoma screening\/prediction and can be used in primary care (PCP) settings NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM glaucoma detection model provides a fully automated detection report for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-09T20:03:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging\",\"datePublished\":\"2024-04-09T20:03:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/\"},\"wordCount\":390,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240408316332\\\/en\\\/2091893\\\/22\\\/ihs_logo_with_white_bg-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/\",\"name\":\"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240408316332\\\/en\\\/2091893\\\/22\\\/ihs_logo_with_white_bg-01.jpg\",\"datePublished\":\"2024-04-09T20:03:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240408316332\\\/en\\\/2091893\\\/22\\\/ihs_logo_with_white_bg-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240408316332\\\/en\\\/2091893\\\/22\\\/ihs_logo_with_white_bg-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/","og_locale":"en_US","og_type":"article","og_title":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend","og_description":"Earlier the company was awarded the Late Age-related Macular Degeneration Screening and Prediction Model. iHealthScreen is the first company that was awarded two US patents by the USPTO on AMD and Glaucoma screening\/prediction and can be used in primary care (PCP) settings NEW YORK&#8211;(BUSINESS WIRE)&#8211;#AI&#8212;iPredictTM glaucoma detection model provides a fully automated detection report for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/","og_site_name":"Pharma Trend","article_published_time":"2024-04-09T20:03:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging","datePublished":"2024-04-09T20:03:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/"},"wordCount":390,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/","url":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/","name":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg","datePublished":"2024-04-09T20:03:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240408316332\/en\/2091893\/22\/ihs_logo_with_white_bg-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ihealthscreen-inc-is-awarded-a-us-patent-on-glaucoma-detection-which-is-based-on-ai-and-color-fundus-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"iHealthScreen Inc. is Awarded a US Patent on Glaucoma Detection, Which Is Based on AI and Color Fundus Imaging"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59183"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59183\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}